BUZZ-Australia's Neurizon Therapeutics drops to 2-year low on discounted placement
Reuters
Dec 23, 2025
BUZZ-Australia's <a href="https://laohu8.com/S/PAAFF">Neurizon Therapeutics</a> drops to 2-year low on discounted placement
** Shares of Australia's Neurizon TherapeuticsNUZ.AX slump as much as 23.6% to A$0.084, their lowest since late November 2023
** Biotech company secures firm commitments to raise A$7.1 million ($4.73 million) via placement at A$0.08 per share
** Placement price represents 27.3% discount to NUZ's last close
** Co adds funding package, together with existing cash reserves and future R&D tax rebates, will fund participation in the HEALEY ALS Platform Trial
** Around 691,000 shares change hands, nearly 1.8x 30-day average
** NUZ down 48.8% YTD
($1 = 1.5020 Australian dollars)
(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.singhchundawat@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.